Astrocyte-microglia interaction drives evolving neuromyelitis optica lesion.

Neuromyelitis optica (NMO) is a severe inflammatory autoimmune CNS disorder triggered by binding of an IgG autoantibody to the aquaporin 4 (AQP4) water channel on astrocytes. Activation of cytolytic complement has been implicated as the major effector of tissue destruction that secondarily involves myelin. We investigated early precytolytic events in the evolving pathophysiology of NMO in mice by continuously infusing IgG (NMO patient serum-derived or AQP4-specific mouse monoclonal), without exogenous complement, into the spinal subarachnoid space. Motor impairment and sublytic NMO-compatible immunopathology were IgG dose dependent, AQP4 dependent, and, unexpectedly, microglia dependent. In vivo spinal cord imaging revealed a striking physical interaction between microglia and astrocytes that required signaling from astrocytes by the C3a fragment of their upregulated complement C3 protein. Astrocytes remained viable but lost AQP4. Previously unappreciated crosstalk between astrocytes and microglia involving early-activated CNS-intrinsic complement components and microglial C3a receptor signaling appears to be a critical driver of the precytolytic phase in the evolving NMO lesion, including initial motor impairment. Our results indicate that microglia merit consideration as a potential target for NMO therapeutic intervention.

[1]  Guo-Yuan Yang,et al.  Microglia exacerbate white matter injury via complement C3/C3aR pathway after hypoperfusion , 2020, Theranostics.

[2]  Ukpong B. Eyo,et al.  Microglia: Lifelong patrolling immune cells of the brain , 2019, Progress in Neurobiology.

[3]  N. Šestan,et al.  Restoration of brain circulation and cellular functions hours post-mortem , 2019, Nature.

[4]  Melanie A. Huntley,et al.  Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies , 2018, Neuron.

[5]  Matthew S. Adams,et al.  Noninvasive, Targeted Creation of Neuromyelitis Optica Pathology in AQP4-IgG Seropositive Rats by Pulsed Focused Ultrasound , 2018, Journal of neuropathology and experimental neurology.

[6]  T. Uchiumi,et al.  Mitochondrial p32/C1qbp Is a Critical Regulator of Dendritic Cell Metabolism and Maturation. , 2018, Cell reports.

[7]  J. Trojanowski,et al.  Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy , 2018, Nature Neuroscience.

[8]  Beth Stevens,et al.  Microglia emerge as central players in brain disease , 2017, Nature Medicine.

[9]  Ian C. Clift,et al.  Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor , 2017, Proceedings of the National Academy of Sciences.

[10]  S. Weigand,et al.  Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica , 2017, Acta Neuropathologica.

[11]  G. Tsokos,et al.  Intracellular Activation of Complement 3 Is Responsible for Intestinal Tissue Damage during Mesenteric Ischemia , 2017, The Journal of Immunology.

[12]  Ukpong B. Eyo,et al.  Microglia–Neuron Communication in Epilepsy , 2017, Glia.

[13]  Mark S. Anderson,et al.  Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4 , 2016, Proceedings of the National Academy of Sciences.

[14]  Ukpong B. Eyo,et al.  Regulation of Physical Microglia–Neuron Interactions by Fractalkine Signaling after Status Epilepticus , 2016, eNeuro.

[15]  A. Verkman,et al.  Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G , 2016, Journal of Neuroinflammation.

[16]  Ki Duk Park,et al.  Glycyrrhizic acid prevents astrocyte death by neuromyelitis optica-specific IgG via inhibition of C1q binding. , 2016, Biochemical and biophysical research communications.

[17]  W. Gan,et al.  Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury , 2016, Nature Communications.

[18]  D. Binder,et al.  The Role of Astrocytic Aquaporin-4 in Synaptic Plasticity and Learning and Memory , 2016, Front. Integr. Neurosci..

[19]  Hui Zheng,et al.  Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease , 2016, The Journal of Neuroscience.

[20]  V. Lennon,et al.  Aquaporin-4 autoimmunity , 2015, Neurology: Neuroimmunology & Neuroinflammation.

[21]  K. Fujihara,et al.  The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model , 2015, Experimental Neurology.

[22]  A. Verkman,et al.  Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59. , 2014, Journal of autoimmunity.

[23]  Ukpong B. Eyo,et al.  Neuronal Hyperactivity Recruits Microglial Processes via Neuronal NMDA Receptors and Microglial P2Y12 Receptors after Status Epilepticus , 2014, The Journal of Neuroscience.

[24]  B. Weinshenker,et al.  AQP4 autoantibody assay performance in clinical laboratory service , 2014, Neurology: Neuroimmunology & Neuroinflammation.

[25]  G. Ingram,et al.  Complement activation in multiple sclerosis plaques: an immunohistochemical analysis , 2014, Acta Neuropathologica Communications.

[26]  C. Lucchinetti,et al.  Neuromyelitis optica IgG stimulates an immunological response in rat astrocyte cultures , 2014, Glia.

[27]  Brian L. West,et al.  Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain , 2014, Neuron.

[28]  Bjoern Peters,et al.  Relapsing–Remitting Central Nervous System Autoimmunity Mediated by GFAP-Specific CD8 T Cells , 2014, The Journal of Immunology.

[29]  C. Drouet,et al.  Human complement C3 deficiency: Th1 induction requires T cell-derived complement C3a and CD46 activation. , 2014, Molecular immunology.

[30]  Y. Itoyama,et al.  The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica , 2014, Brain pathology.

[31]  T. Reinheckel,et al.  Intracellular Complement Activation Sustains T Cell Homeostasis and Mediates Effector Differentiation , 2013, Immunity.

[32]  T. Bourgeron,et al.  Progress toward treatments for synaptic defects in autism , 2013, Nature Medicine.

[33]  A. Verkman,et al.  C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica , 2013, Acta Neuropathologica.

[34]  G. Dunn,et al.  Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment , 2012, Journal of psychopharmacology.

[35]  R. Ransohoff,et al.  Innate immunity in the central nervous system. , 2012, The Journal of clinical investigation.

[36]  T. Hughes,et al.  C3-dependent mechanism of microglial priming relevant to multiple sclerosis , 2012, Proceedings of the National Academy of Sciences.

[37]  M. Romero,et al.  Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes , 2011, Proceedings of the National Academy of Sciences.

[38]  Graham M Lord,et al.  Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells , 2010, Nature Immunology.

[39]  R. Polin,et al.  Complement Component C1q Mediates Mitochondria-Driven Oxidative Stress in Neonatal Hypoxic–Ischemic Brain Injury , 2010, The Journal of Neuroscience.

[40]  M. Papadopoulos,et al.  Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. , 2010, Brain : a journal of neurology.

[41]  Y. Itoyama,et al.  Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo , 2009, Annals of neurology.

[42]  A. Bar-Or,et al.  Functional Consequences of Neuromyelitis Optica-IgG Astrocyte Interactions on Blood-Brain Barrier Permeability and Granulocyte Recruitment1 , 2008, The Journal of Immunology.

[43]  C. Lucchinetti,et al.  Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica , 2007, Neurology.

[44]  M. Zhuo,et al.  ATP‐induced chemotaxis of microglial processes requires P2Y receptor‐activated initiation of outward potassium currents , 2007, Glia.

[45]  J. Parisi,et al.  Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. , 2007, Brain : a journal of neurology.

[46]  Y. Itoyama,et al.  Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. , 2007, Brain : a journal of neurology.

[47]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[48]  B. Becher,et al.  Experimental autoimmune encephalomyelitis repressed by microglial paralysis , 2005, Nature Medicine.

[49]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[50]  F. Silverstein,et al.  Complement Activation Contributes to Hypoxic-Ischemic Brain Injury in Neonatal Rats , 2003, The Journal of Neuroscience.

[51]  Hans Lassmann,et al.  A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. , 2002, Brain : a journal of neurology.

[52]  H. Lassmann,et al.  Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia , 1994, The Journal of experimental medicine.

[53]  Daishi Tian,et al.  Dual Functions of Microglia in Ischemic Stroke , 2019, Neuroscience Bulletin.

[54]  Fang Wang,et al.  Aquaporin-4 promotes memory consolidation in Morris water maze , 2011, Brain Structure and Function.

[55]  V. Lennon,et al.  Clinical utility of testing AQP4-IgG in CSF , 2016, Neurology: Neuroimmunology & Neuroinflammation.